Webinars and Sponsored Roundtables — Register Now
Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology,
Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Siemens Healthcare Diagnostics
| Company | Siemens Healthcare Diagnostics |
|---|---|
| Name of urinalysis instrument | CLINITEK Advantus Analyzer |
| Contact | Aohua Sang |
| City, State | Tarrytown, NY |
| Phone | 914-631-8000 |
| Website | |
| Type of instrument | urine chemistry |
| Instrument list price | $7,392 (avail. via purchase or reagent rental agreement) |
| First year instrument sold in the U.S. | 2006 |
| Approximate No. of units in clinical use in the U.S./outside the U.S. | 3,000/2,000 (in Europe, Asia–Pacific, Latin America, Canada) |
| Foreign countries where company markets instrument | Europe, Asia–Pacific, Latin America, Canada |
| Country where instrument is designed/manufactured | U.S. and United Kingdom/Poland |
| Human languages (other than English) supported | French, German, Italian, Japanese, Spanish, more |
| Intended urine sample volume per day | 36–50 |
| Dimensions (H×W×D) | 12.75 × 15.75 × 13.75 in. |
| Weight fully loaded with reagents/without reagents | 17 lbs./16 lbs. |
| Power requirements | 100–240 VAC (50–60 Hz) |
| Mean time between failure of instrument | 81 days |
| Events that cause instrument to lock or stop analysis | QC failure, short sample, barcode/sample ID misread, result error, sampling error, hardware failure, more |
| • Urine chemistry tests available on instrument in the U.S. | bilirubin (negative–large), hemoglobin (negative–large), glucose (negative–≥1,000 mg/dL), ketone (negative–≥80 mg/dL), leukocyte esterase (negative–large), nitrite (positive/negative), pH (5.0–≥9.0), protein (negative–300 mg/dL), specific gravity (≤1.005–≥1.030), urobilinogen (0.2–≥8.0 EU/dL) |
| • Color compensation pad included/Flagging thresholds customizable | yes/yes |
| • Test strip configuration | loosely packed in bottles |
| • Calibration required after each test strip lot No. change | no |
| • Frequency of customer-performed calibration/Form of calibration | instrument self-calibrates for every strip/dry |
| • How results are displayed for urine chemistry | semiquantitative |
| • Specific gravity correction for protein/glucose | no/no |
| • Microscopy/sediment technology | — |
| • Microscopy/sediment analysis parameters | — |
| • Flagging thresholds customizable | — |
| • Instrument eliminates amorphous crystal interference before sample analysis | — |
| • How results are displayed for microscopy/sediment | — |
| • Reporting format customizable | — |
| • No. of results that can be held in internal memory | — |
| Reagent shelf life/storage temp. for unopened containers of calibrator | — (no calibrator needed) |
| Reagent shelf life/storage temp. for opened containers of calibrator | — (no calibrator needed) |
| Reagent shelf life/storage temp. for unopened containers of control reagent | 730 days/2–8°C |
| Reagent shelf life/storage temp. for opened containers of control reagent | 30 days/20–25°C |
| Reagent barcode-reading capability | yes, for all tests (can read Data Matrix, more) |
| How often quality control samples are run | configurable: 1 hour to 99 days (can use other companies’ QC products) |
| Sample throughput per hour/Time to first result for chemistry | 500/62 seconds, then every 7 seconds |
| Sample throughput per hour/Time to first result for microscopy/sediment | — |
| Analyzer has stat mode | yes |
| FDA approved for body fluid analysis | yes (for urine) |
| Sample dilutions required for urinalysis/body fluid analysis | no/not applicable |
| Minimum width of sample tube/Minimum length of sample tube | 7 mm/76 mm |
| Conditions or substances that prevent a sample from being run | none |
| Means of sample ID entry | barcode scan, manual entry, worklist download from host |
| Built-in liquid-level sensing for samples | no |
| Information that can be barcode scanned on instrument | operator and specimen identifier, reagent lot No., more |
| Compatible with laboratory automation systems | no |
| How LOINC codes for results are made available | functionality not provided |
| Software includes reflex testing/cross-check functionality | no/no |
| Instrument automatically generates consolidated report* | yes |
| Instrument archives patient data | no |
| Instrument connections to transfer information | data-management system that connects to LIS or EHR, directly to LIS or EHR, via commercial middleware, more |
| Interface standards or formats supported | ASTM 1394-91, Siemens proprietary protocol |
| Bidirectional interface | yes, to other companies’ LISs (no third-party tool or software required for interface) |
| Test results can be transmitted to LIS as soon as tests completed | yes |
| Connection to LIS/EHR to upload patient and QC results | LIS and EHR: direct serial, hospital network |
| Information included in transmission to data-management system | device unique identifier, operator ID, specimen ID, result, QC identifier, strip type, reagent lot and expiration |
| Training included with instrument purchase | yes (4 hours at choice of customer or vendor site; follow-up training available for no extra charge) |
| Approximate scheduled maintenance time required | 30 min. per shift; 30 min. daily; 90 min. weekly; 270 min. monthly |
| Onboard diagnostics for troubleshooting | yes |
| Provide list of client sites to potential customers on request | yes (partial list of comparable sites but prospective client must sign a nondisclosure agreement) |
| Clients restricted from sharing their experience with company or software | no |
| Distinguishing instrument features (supplied by company) | broad test menu: routine UA testing for kidney functions, CKD, AKI, UTI, diabetes mellitus, more; auto-checks proprietary technology for humidity exposure, sample interference, auto. strip ID |
| *chemistry and microscopy results in one report; Note: a dash in lieu of an answer means company did not answer; question or question is not applicable | †also sold via distribution partners |